BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wensink D, Wagenmakers MAEM, Langendonk JG. Afamelanotide for prevention of phototoxicity in erythropoietic protoporphyria. Expert Rev Clin Pharmacol 2021;14:151-60. [PMID: 33507118 DOI: 10.1080/17512433.2021.1879638] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Di Pierro E, Granata F, De Canio M, Rossi M, Ricci A, Marcacci M, De Luca G, Sarno L, Barbieri L, Ventura P, Graziadei G. Recognized and Emerging Features of Erythropoietic and X-Linked Protoporphyria. Diagnostics (Basel) 2022;12:151. [PMID: 35054318 DOI: 10.3390/diagnostics12010151] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Durek T, Kaas Q, White AM, Weidmann J, Fuaad AA, Cheneval O, Schroeder CI, de Veer SJ, Dellsén A, Österlund T, Larsson N, Knerr L, Bauer U, Plowright AT, Craik DJ. Melanocortin 1 Receptor Agonists Based on a Bivalent, Bicyclic Peptide Framework. J Med Chem 2021;64:9906-15. [PMID: 34197114 DOI: 10.1021/acs.jmedchem.1c00095] [Reference Citation Analysis]
3 Francesca G, Nicolli A, Colaiocco A, Di Pierro E, Graziadei G. Psychological Aspect and Quality of Life in Porphyrias: A Review. Diagnostics 2022;12:1193. [DOI: 10.3390/diagnostics12051193] [Reference Citation Analysis]
4 Wensink D, Wagenmakers MAEM, Qi H, Wilson JHP, Langendonk JG. Objective light exposure measurements and circadian rhythm in patients with erythropoietic protoporphyria: A case-control study. Mol Genet Metab 2022:S1096-7192(21)01202-6. [PMID: 35034844 DOI: 10.1016/j.ymgme.2021.12.017] [Reference Citation Analysis]